Back to top

Pfizer wins FDA label expansion for Padcev plus Merck’s Keytruda in bladder cancer

Pfizer wins FDA label expansion for Padcev plus Merck’s Keytruda in bladder cancer

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Astellas Pharma Inc. (ALPMY)

Merck & Co., Inc. (MRK)

Pfizer Inc. (PFE)